Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients
Clinical trial NCT03464916 · COMPLETED
Trial details
- NCT number
- NCT03464916
- Sponsor
- Sorrento Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2020-08-23
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.